These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7742545)

  • 21. Alternative immunoassay for tartrate-resistant acid phosphatase isoform 5b using the fluorogenic substrate naphthol ASBI-phosphate and heparin.
    Janckila AJ; Simons RM; Yam LT
    Clin Chim Acta; 2004 Sep; 347(1-2):157-67. PubMed ID: 15313154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein-tyrosine phosphatase activity of hairy cell tartrate-resistant acid phosphatase.
    Janckila AJ; Woodford TA; Lam KW; Li CY; Yam LT
    Leukemia; 1992 Mar; 6(3):199-203. PubMed ID: 1564956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tartrate-resistant acid phosphatase is not an exclusive marker for mouse osteoclasts in cell culture.
    Modderman WE; Tuinenburg-Bol Raap AC; Nijweide PJ
    Bone; 1991; 12(2):81-7. PubMed ID: 2064844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of hairy-cell leukaemia by tartrate-resistant acid phosphatase activity in paraffin-embedded tissue sections.
    Grouls V
    J Clin Pathol; 1980 Jun; 33(6):552-4. PubMed ID: 7400358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of the tartrate-resistant acid phosphatase detection by histochemical method.
    Galvão MJ; Santos A; Ribeiro MD; Ferreira A; Nolasco F
    Eur J Histochem; 2011 Feb; 55(1):e1. PubMed ID: 21556115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methods in pathology. Immunophenotype of hairy cell leukemia in paraffin sections.
    Strickler JG; Schmidt CM; Wick MR
    Mod Pathol; 1990 Jul; 3(4):518-23. PubMed ID: 2217156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients.
    Mose S; Menzel C; Kurth AA; Obert K; Breidert I; Borowsky K; Böttcher HD
    Anticancer Res; 2003; 23(3C):2783-8. PubMed ID: 12926113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and characterization of novel monoclonal antibodies against tartrate-resistant acid phosphatase 5.
    Ohashi T; Miura T; Igarashi Y; Kiyokawa I; Sato Y; Sasagawa K; Katagiri K; Mochizuki Y; Tomonaga T; Nomura F; Kojima R; Katayama K
    Hybridoma (Larchmt); 2006 Dec; 25(6):358-66. PubMed ID: 17203998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity.
    Janckila AJ; Takahashi K; Sun SZ; Yam LT
    Clin Chem; 2001 Jan; 47(1):74-80. PubMed ID: 11148180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reference intervals of serum tartrate-resistant acid phosphatase type 5b activity measured with a novel assay in Japanese subjects.
    Nishizawa Y; Inaba M; Ishii M; Yamashita H; Miki T; Goto H; Yamada S; Chaki O; Kurasawa K; Mochizuki Y
    J Bone Miner Metab; 2008; 26(3):265-70. PubMed ID: 18470668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The utility of BRAF V600E mutation-specific antibody VE1 for the diagnosis of hairy cell leukemia.
    Uppal G; Ly V; Wang ZX; Bajaj R; Solomides CC; Banks PM; Medeiros LJ; Peiper SC; Gong JZ
    Am J Clin Pathol; 2015 Jan; 143(1):120-5. PubMed ID: 25511150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay.
    Wu ZQ; Zhang Y; Xie E; Song WJ; Yang RX; Yan CJ; Zhang BF; Xu HG
    PLoS One; 2016; 11(1):e0147554. PubMed ID: 26800211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis.
    Janckila AJ; Neustadt DH; Nakasato YR; Halleen JM; Hentunen T; Yam LT
    Clin Chim Acta; 2002 Jun; 320(1-2):49-58. PubMed ID: 11983200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients.
    Chao TY; Ho CL; Lee SH; Chen MM; Janckila A; Yam LT
    J Biomed Sci; 2004; 11(4):511-6. PubMed ID: 15153786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment and characterization of bone marrow stromal cell lines that support osteoclastogenesis.
    Matsumoto HN; Tamura M; Denhardt DT; Obinata M; Noda M
    Endocrinology; 1995 Sep; 136(9):4084-91. PubMed ID: 7544276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High specificity of combined TRAP and DBA.44 expression for hairy cell leukemia.
    Went PT; Zimpfer A; Pehrs AC; Sabattini E; Pileri SA; Maurer R; Terracciano L; Tzankov A; Sauter G; Dirnhofer S
    Am J Surg Pathol; 2005 Apr; 29(4):474-8. PubMed ID: 15767800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
    Terpos E; de la Fuente J; Szydlo R; Hatjiharissi E; Viniou N; Meletis J; Yataganas X; Goldman JM; Rahemtulla A
    Int J Cancer; 2003 Sep; 106(3):455-7. PubMed ID: 12845688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that tartrate-resistant acid phosphatases from osteoclastomas and hairy cell leukemia spleen are members of a multigene family.
    Lau KH; Stepan JJ; Yoo A; Mohan S; Baylink DJ
    Int J Biochem; 1991; 23(11):1237-44. PubMed ID: 1794448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.
    Hannon RA; Clowes JA; Eagleton AC; Al Hadari A; Eastell R; Blumsohn A
    Bone; 2004 Jan; 34(1):187-94. PubMed ID: 14751577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An assessment of the usefulness of immunohistochemical stains in the diagnosis of hairy cell leukemia.
    Sherman MJ; Hanson CA; Hoyer JD
    Am J Clin Pathol; 2011 Sep; 136(3):390-9. PubMed ID: 21846914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.